Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lycan TW"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab.
    Autorzy:
    Bloomer CH; Internal Medicine, Atrium Health at Wake Forest Baptist, Winston Salem, NC, USA.
    Annabathula RV; Internal Medicine, Atrium Health at Wake Forest Baptist, Winston Salem, NC, USA.
    Aggarwal V; Internal Medicine, Atrium Health at Wake Forest Baptist, Winston Salem, NC, USA.
    Upadhya B; Internal Medicine, Atrium Health at Wake Forest Baptist, Winston Salem, NC, USA.
    Lycan TW; Internal Medicine, Atrium Health at Wake Forest Baptist, Winston Salem, NC, USA.
    Pokaż więcej
    Źródło:
    Case reports in immunology [Case Reports Immunol] 2022 Oct 12; Vol. 2022, pp. 7971169. Date of Electronic Publication: 2022 Oct 12 (Print Publication: 2022).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma.
    Autorzy:
    Hughes RT; Department of Radiation Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Porosnicu M; Depatment of Internal Medicine-Section of Hematology and Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Levine BJ; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Lycan TW Jr; Depatment of Internal Medicine-Section of Hematology and Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Shenker RF; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.
    Frizzell BA; Department of Radiation Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Greven KM; Department of Radiation Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
    Pokaż więcej
    Źródło:
    Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2021 Oct; Vol. 65 (6), pp. 796-805. Date of Electronic Publication: 2021 Jul 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents*/therapeutic use
    Carcinoma, Squamous Cell*/drug therapy
    Head and Neck Neoplasms*/therapy
    Chemoradiotherapy ; Cisplatin ; Humans ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    An evidence-based medicine approach for case presentations by trainees.
    Autorzy:
    Lycan TW; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Ahmed T; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Seegars MB; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Patel M; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Woods R; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Melin SA; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
    Pokaż więcej
    Źródło:
    The clinical teacher [Clin Teach] 2019 Dec; Vol. 16 (6), pp. 575-579. Date of Electronic Publication: 2018 Dec 03.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Evidence-Based Medicine/*education
    Internship and Residency/*organization & administration
    Neoplasms/*pathology
    Neoplasms/*therapy
    Teaching/*organization & administration
    Attitude of Health Personnel ; Clinical Competence ; Humans ; Internship and Residency/standards ; Interprofessional Relations ; Teaching/standards
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
    Autorzy:
    Lycan TW; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Pardee TS; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Petty WJ; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Bonomi M; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Alistar A; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Lamar ZS; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Isom S; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Chan MD; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Miller AA; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
    Ruiz J; Department of Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.; W.G. (Bill) Hefner Veteran Administration Medical Center, Cancer Center, Salisbury, NC, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Oct 12; Vol. 11 (10), pp. e0164244. Date of Electronic Publication: 2016 Oct 12 (Print Publication: 2016).
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article
    MeSH Terms:
    Antineoplastic Agents/*therapeutic use
    Caprylates/*therapeutic use
    Lung/*drug effects
    Lung Neoplasms/*drug therapy
    Small Cell Lung Carcinoma/*drug therapy
    Sulfides/*therapeutic use
    Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Caprylates/administration & dosage ; Cell Line, Tumor ; Female ; Humans ; Kaplan-Meier Estimate ; Lung/pathology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Small Cell Lung Carcinoma/pathology ; Sulfides/administration & dosage ; Topoisomerase I Inhibitors/administration & dosage ; Topoisomerase I Inhibitors/therapeutic use ; Topotecan/administration & dosage ; Topotecan/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies